powered by
▸
healthparse
Search
Cohort Builder
Tools
▾
KOL Finder
Territories
Drug Compare
AI Query
Research
Browse
▾
By state
By specialty
Pricing
Search
Cohort Builder
Tools
KOL Finder
Territories
Drug Compare
AI Query
Research
Browse
By state
By specialty
Pricing
PROVIDER PROFILE · NPI 1447511399
Megan Baumgardner
DO
Neurology
Lees Summit,
MO
I
CROSS-REFERENCE
Related data on other Healthparse brands
ProviderScore
OIG/SAM exclusion screening, sanctions history
Healthparse Signals
Monitor this provider for changes — dated NPI change events
INDUSTRY PAYMENTS · OPEN PAYMENTS · 2025
No data available for this provider in 2025.
QUALITY · MIPS · 2024
Final MIPS score
82.6
Quality
76.1
Cost
65.8
Improvement activities
40.0
Promoting interop.
100.0
Payment adjustment
0.32%
Group
PRESCRIBING · PART D · 2024
Total Rx claims
1,397
Beneficiaries
—
Total drug cost
$43K
Distinct drugs
7
Brand share
5.5%
Top prescribed drugs
Donepezil Hcl
664 claims
Memantine Hcl
387 claims
Sertraline Hcl
158 claims
Rivastigmine
91 claims
Galantamine Hbr
52 claims
MEDICARE UTILIZATION · PART B · 2024
Total beneficiaries
441
Unique beneficiaries
—
Total services
506
Distinct HCPCS
5
Medicare payment
$71K
Peer benchmark
Q1
Q2
Q3
Q4
Q5
Total Medicare services vs. 312 Neurology providers in MO — below median (cohort median 552).